Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Odonate Therapeutics, Inc. (ODT)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/10/2021 | EcoR1 Capital, LLC | 10% Owner | Sale | Common Stock | 5M | $1.66 | $8.3M | See Note 1 | 12/01/2021 |
| 12/10/2021 | EcoR1 Capital, LLC | 10% Owner | Sale | Common Stock | 545k | $1.55 | $847.4k | See Note 1 | 12/01/2021 |
| 12/09/2021 | EcoR1 Capital, LLC | 10% Owner | Sale | Common Stock | 156.7k | $1.82 | $285k | See Note 1 | 12/01/2021 |
| 12/01/2021 | EcoR1 Capital, LLC | 10% Owner | Purchase | Common Stock | 185.9k | $1.66 | $308.7k | See Note 1 | 12/01/2021 |
| 12/01/2021 | EcoR1 Capital, LLC | 10% Owner | Sale | Common Stock | 185.9k | $1.66 | $308.7k | See Note 1 | 12/01/2021 |
| 11/24/2021 | Boxer Capital, LLC | 10% Owner | Sale | Common Stock | 200k | $1.57 | $313.7k | | 11/22/2021 |
| 11/22/2021 | Boxer Capital, LLC | 10% Owner | Sale | Common Stock | 200k | $1.55 | $309.7k | | 11/22/2021 |
| 11/19/2021 | Boxer Capital, LLC | 10% Owner | Sale | Common Stock | 150k | $1.84 | $276.3k | | 11/17/2021 |
| 11/19/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 365.3k | $1.92 | $699.9k | By LP | 11/17/2021 |
| 11/19/2021 | Davis Aaron I. | 10% Owner | Sale | Common Stock | 150k | $1.84 | $276.3k | See footnote | 11/17/2021 |
| 11/19/2021 | Davis Aaron I. | 10% Owner | Sale | Common Stock | 30k | $1.92 | $57.5k | | 11/17/2021 |
| 11/18/2021 | Davis Aaron I. | 10% Owner | Sale | Common Stock | 250k | $1.95 | $487.2k | See footnote | 11/17/2021 |
| 11/18/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 212.4k | $1.97 | $418.6k | By LP | 11/17/2021 |
| 11/18/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 500k | $1.88 | $940.6k | By LP | 11/17/2021 |
| 11/18/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 381.8k | $1.89 | $722.6k | By LP | 11/17/2021 |
| 11/18/2021 | Boxer Capital, LLC | 10% Owner | Sale | Common Stock | 250k | $1.95 | $487.2k | | 11/17/2021 |
| 11/17/2021 | Boxer Capital, LLC | 10% Owner | Sale | Common Stock | 600k | $2.17 | $1.3M | | 11/17/2021 |
| 11/17/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 468.8k | $2.66 | $1.2M | By LP | 11/17/2021 |
| 11/17/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 31.2k | $1.99 | $62.1k | By LP | 11/17/2021 |
| 11/17/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 500k | $2.02 | $1M | By LP | 11/17/2021 |
| 11/17/2021 | TANG KEVIN C | CEO | Sale | Common Stock | 287.6k | $2.20 | $632.2k | By LP | 11/17/2021 |
| 11/17/2021 | Davis Aaron I. | 10% Owner | Sale | Common Stock | 600k | $2.17 | $1.3M | See footnote | 11/17/2021 |
| 11/17/2021 | Davis Aaron I. | 10% Owner | Sale | Common Stock | 170k | $2.23 | $379.7k | | 11/17/2021 |
| 03/15/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Common Stock | 99 | $16.22 | $1.6k | | 03/15/2021 |
| 03/15/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Employee Stock Option (Right to Buy) | 99 | $19.08 | $1.9k | | 03/15/2021 |
| 03/15/2021 | Hearne Michael S | CFO | Grant | Common Stock | 37 | $16.22 | $600.1 | | 03/15/2021 |
| 03/15/2021 | Hearne Michael S | CFO | Grant | Employee Stock Option (Right to Buy) | 37 | $19.08 | $706 | | 03/15/2021 |
| 02/26/2021 | Hearne Michael S | CFO | Grant | Common Stock | 34 | $17.89 | $608.3 | | 02/26/2021 |
| 02/26/2021 | Hearne Michael S | CFO | Grant | Employee Stock Option (Right to Buy) | 34 | $21.05 | $715.7 | | 02/26/2021 |
| 02/26/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Common Stock | 90 | $17.89 | $1.6k | | 02/26/2021 |
| 02/26/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Employee Stock Option (Right to Buy) | 90 | $21.05 | $1.9k | | 02/26/2021 |
| 02/12/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Common Stock | 76 | $21.19 | $1.6k | | 02/12/2021 |
| 02/12/2021 | O'Connell Joseph P | Chief Medical Officer | Grant | Employee Stock Option (Right to Buy) | 76 | $24.93 | $1.9k | | 02/12/2021 |
| 02/12/2021 | Hearne Michael S | CFO | Grant | Common Stock | 28 | $21.19 | $593.3 | | 02/12/2021 |
| 02/12/2021 | Hearne Michael S | CFO | Grant | Employee Stock Option (Right to Buy) | 28 | $24.93 | $698 | | 02/12/2021 |
|
|